Form 8-K BOSTON SCIENTIFIC CORP For: Apr 24
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500, Dow set to open lower as Gulf tensions send oil to over six-week high
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Boston Scientific (BSX) PT Raised to $77 at Oppenheimer
April 25, 2024 10:00 AM EDTOppenheimer analyst Steven Lichtman raised the price target on Boston Scientific (NYSE: BSX) to $77.00 (from $68.00) while maintaining a Outperform rating.
The analyst comments "BSX delivered 1Q24 sales meaningfully ahead of the Street (13% organic y/y). EPS was also beat ($0.56 versus our/Street's... More
Boston Scientific (BSX) PT Raised to $82 at RBC Capital
April 25, 2024 6:40 AM EDTRBC Capital analyst Shagun Singh raised the price target on Boston Scientific (NYSE: BSX) to $82.00 (from $78.00) while maintaining a Outperform rating.
The analyst comments "BSX delivered solid beat with an upside surprise of ~5% and ~10% on sales and EPS, respectively. Given this momentum (+660bps... More
Boston Scientific (BSX) PT Raised to $82 at Wells Fargo
April 25, 2024 5:23 AM EDTWells Fargo analyst Lawrence Biegelsen raised the price target on Boston Scientific (NYSE: BSX) to $82.00 (from $72.00) while maintaining a Overweight rating.
The analyst comments "Today (4/24), BSX reported Q1 rev/EPS ahead of Street and raised 2024 rev guidance by 250bps at the mdpt to 10-12%.... More
Boston Scientific (BSX) PT Raised to $80 at BTIG
April 24, 2024 3:14 PM EDTBTIG analyst Marie Thibault raised the price target on Boston Scientific (NYSE: BSX) to $80.00 (from $74.00) while maintaining a Buy rating.
The analyst comments "After a record-setting 2023, Boston Scientific is starting 2024 at an even faster pace. BSX reported Q1 revenue of $3.856B (+13.8% y/y rep., +13.1% org.) and adj. EPS of $0.56 (consensus $3.684B and $0.51), well above its guidance... More
